The most common germline alterations found in patients with metastatic castrate‐resistant PCa were in BRCA2 (5.3%), CHEK2 (1.9%), ATM (1.6%), and BRCA1 (0.9%). Here, CHEK2 is linked to posterior cortical atrophy.